CellMax-DNA Genetic Cancer Risk Test identifies 25 known hereditary cancers.
CLIA-Certified Laboratory, Sunnyvale, CA, USA
CellMax-DNA has the broadest gene panel for determining risk for hereditary cancers — to help you protect yourself and your family.
This convenient saliva test analyzes 98 genes across 25 known hereditary cancers, including Lung, Breast, Colorectal, Prostate, Oral, Stomach, Bladder, Pancreas, Kidney, Thyroid, Ovary and more.
Mutations can increase genetic cancer risk by 20 times. Individuals who inherit mutated genes associated with cancer have a greater risk of getting cancer and tend to get their cancers earlier in life. Additionally, the cancer is usually more aggressive.
The CellMax-DNA test result includes a personalized health risk management plan, enabling you to manage and take control of your health. Knowing your risk, you can tune your cancer screening frequency.
CellMax SMSEQ™ Platform
CellMax Life’s DNA test uses next generation sequencing technology, with an analytical specificity of ≥99.999%. This patented technology, combined with years of research and development advancements, allows CellMax to provide an highly affordable and comprehensive genetic cancer risk test.